We use cookies for a better user experience. Read our Privacy Policy

I Agree

Europe Platelet Rich Plasma Market

Platelet Rich Plasma Market (By Types: Pure-Platelet Rich Plasma, Leukocyte-Platelet Rich Plasma and Leukocyte-Platelet Rich Fibrin; By Origin: Autologous, Allogenic and Homologous; By Applications: Orthopedic Surgery, Cosmetic Surgery, General Surgery, Neurosurgery and Other Surgeries) - Europe Industry Analysis, Size, Share, Growth, Trends & Forecast 2014 - 2022

Platelet rich plasma (PRP) is a blood plasma product that contains elevated level of platelets and growth factors (at least four to ten times) than normal blood concentration. PRP is also called as also called platelet enriched plasma and platelet gel. While mostly derived from patient’s own blood, platelet rich plasma is widely used in the treatment of diseases such as orthopedic diseases, neurological diseases, and other minor injuries that require outpatient surgeries. Rising incidence of diseases such as orthopedic diseases, sports injuries, cardiovascular diseases, obesity, and neurological diseases and introduction of various devices for PRP preparation are the key factors that are likely to drive market growth. In addition, growing awareness about PRP therapy and its advantages, and aging population more prone to injuries and surgeries are the other factors that boost market growth. However, high cost of the devices and therapy and threat of treatment failures are some of the factors restricting the market growth to some extent.

The autologous PRP segment dominated the PRP market in Europe in 2013. The dominance of this market segment was due to increasing demand for allogenic platelet rich plasma products. Thus, the allogenic segment is estimated to grow at the highest growth rate during the forecast period from 2014 to 2022. The growth of this market segment was majorly due to reduced wound healing time and high concentration of growth factors containing platelet rich plasma products. In case of a patient diagnosed with one of the blood disorders (leukemia, hemocytopenia, etc) with less number of platelets in the blood and without any significant clinical action, where allogenic PRP treatment would be recommended.

Orthopedic was the largest application segment in 2013, accounting for 38.3% share of the PRP market in Europe. Large number of orthopedic and sports injuries and rise in geriatric population are the major factors driving the growth of this application segment. PRP products are widely used in cosmetic surgeries to enhance the rate of injury healing, improve facial aesthetics, and facelift treatments. In addition, cost-effectiveness and multiple applications of PRP in cosmetic surgeries are the major factors accelerating the growth of this segment. Therefore, these factors collectively propel the growth of cosmetic surgery application segment and it is estimated to grow at a highest rate during the forecast period from 2014 to 2022. 

Geographically, the Europe platelet rich plasma market has been segmented as U.K., Germany, Italy, France, Spain and Rest of Europe. In 2013, U.K. dominated the Europe PRP market primarily due to increasing prevalence of orthopedic and reconstructive procedures and growing number of bariatric surgeries. Thus, PRP therapy is gaining wider acceptability as it provides effective treatment and faster recovery. For instance, tennis elbow affects around 300,000 people in the U.K. every year, where PRP is the most preferred treatment option. Moreover, growing preference for PRP therapy for sports injuries would boost market growth in the U.K.

The Europe PRP market is highly fragmented with the presence of a large number of small and large multinational players. Companies such as Arthrex, Inc., Biomet, Inc., and EmCyte Corporation dominated the Europe PRP market in 2013. Other minor players present in the Europe PRP market include AdiStem Ltd., Glofinn Oy, Medira Ltd., and Regen Lab SA.

Europe Platelet Rich Plasma Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

 
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
      1.3.1 Secondary Research
      1.3.2 Primary Research
      1.3.3 Assumptions
1.4 List of Abbreviations
 
Chapter 2 Executive Summary
2.1 Market Snapshot: Europe PRP Market (2013 & 2022) 
2.2 Europe PRP Market, by Types, 2013 (USD Million) 
2.3 Europe PRP Market, by Origin, 2013 (USD Million) 
2.4 Europe PRP Market, by Applications, 2013 (USD Million) 
2.5 Comparative Analysis: Europe PRP Market, By Country, 2013 & 2022 (Value %)
 
Chapter 3 Market Overview
3.1 Overview
3.2 Value Chain Analysis
3.3 Regulatory Framework
3.4 Market Drivers
      3.4.1 Increasing cosmetic surgeries likely to accelerate market growth
      3.4.2 Technological advancements and regulatory approvals for new devices are contributing to the growth of the PRP market
3.5 Restraints
      3.5.1 Threat of therapy failure and disease transfer (in case of allogenic and homologous PRP) could restrain market growth
3.6 Opportunities
      3.6.1 Development of technologically advanced devices and new application areas of PRP technology would open new avenues
3.7 Reimbursement Scenario
3.8 Porter’s Five Forces Analysis of the Europe Platelet Rich Plasma (PRP) Market
      3.8.1 Bargaining power of suppliers
      3.8.2 Bargaining power of buyers
      3.8.3 Threat of substitutes
      3.8.4 Threat of new entrants
      3.8.5 Competitive rivalry
3.9 Market Attractiveness Analysis: Europe Platelet Rich Plasma (PRP) Market, by Country, 2013
3.10 Competitive Landscape
      3.10.1 Market Share Analysis, by Key Players: Europe Platelet Rich Plasma Market, 2013 (Value %)
 
Chapter 4 Europe Platelet Rich Plasma Market, by Origin
4.1 Overview
      4.1.1 Europe PRP Market Revenue, by Origin, 2012 – 2022 (USD Million) 
4.2 Average Pricing Analysis
4.3 Autologous Platelet-Rich Plasma
      4.3.1 Europe Autologous PRP Market Revenue, 2012 – 2022 (USD Million) 
4.4 Allogenic Platelet-Rich Plasma
      4.4.1 Europe Allogenic PRP Market Revenue, 2012 – 2022 (USD Million) 
4.5 Homologous  Platelet-Rich Plasma
      4.5.1 Europe Homologous PRP Market Revenue, 2012 – 2022 (USD Million) 
 
Chapter 5 Europe Platelet Rich Plasma Market, by Types
5.1 Overview
      5.1.1 Europe PRP Market Revenue, by Types, 2012 – 2022 (USD Million) 
5.2 Pure Platelet-Rich Plasma (P-PRP) 
      5.2.1 Europe Pure PRP Market Revenue, 2012 – 2022 (USD Million) 
5.3 Leukocyte-Rich Platelet-Rich Plasma (L-PRP) 
      5.3.1 Europe Leukocyte Rich PRP Market Revenue, 2012 – 2022 (USD Million) 
5.4 Pure Platelet-Rich Fibrin (P-PRF)/Leukocyte-Rich Platelet-Rich Fibrin (L-PRF) 
      5.4.1 Europe P-PRF/L-PRF PRP Market Revenue, 2012 – 2022 (USD Million) 
 
Chapter 6 Europe Platelet Rich Plasma Market, by Applications
6.1 Overview
      6.1.1 Europe PRP Market Revenue, by Applications, 2012 – 2022 (USD Million) 
6.2 Orthopedic
      6.2.1 Europe Orthopedic PRP Market Revenue, 2012 – 2022 (USD Million) 
6.3 Cosmetic Surgery
      6.3.1 Europe Cosmetic Surgery PRP Market Revenue, 2012 – 2022 (USD Million) 
6.4 General Surgery
      6.4.1 Europe General Surgery PRP Market Revenue, 2012 – 2022 (USD Million) 
6.5 Neurosurgery
      6.5.1 Europe Neurosurgery PRP Market Revenue, 2012 – 2022 (USD Million) 
6.6 Other Surgeries (Urology, Cardiothoracic, Oral & Maxillofacial and Periodontal) 
      6.6.1 Europe Other Surgeries PRP Market Revenue, 2012 – 2022 (USD Million) 
 
Chapter 7 Europe Platelet Rich Plasma Market, by Country
7.1 Overview
      7.1.1 Europe PRP Market Revenue, by Country, 2012 – 2022 (USD Million) 
7.2 U.K. 
      7.2.1 U.K. PRP Market Revenue, 2012 – 2022 (USD Million) 
7.3 Germany
      7.3.1 Germany PRP Market Revenue, 2012 – 2022 (USD Million) 
7.4 France
      7.4.1 France PRP Market Revenue, 2012 – 2022 (USD Million) 
7.5 Italy
      7.5.1 Italy PRP Market Revenue, 2012 – 2022 (USD Million) 
7.6 Spain
      7.6.1 Spain PRP Market Revenue, 2012 – 2022 (USD Million) 
7.7 Rest of Europe
      7.7.1 Rest of Europe PRP Market Revenue, 2012 – 2022 (USD Million) 
 
Chapter 8 Recommendations
8.1 Development of new PRP devices and discovery of new application areas would fuel the market growth
8.2 Commercialization and promotion of technologically advanced PRP devices to boost market growth
 
Chapter 9 Company Profiles
9.1 AdiStem Ltd. 
      9.1.1 Company Overview
      9.1.2 Financial Overview
      9.1.3 Product Portfolio
      9.1.4 Business Strategies
      9.1.5 Recent Developments
9.2 Arthrex, Inc. 
      9.2.1 Company Overview
      9.2.2 Financial Overview
      9.2.3 Product Portfolio
      9.2.4 Business Strategies
      9.2.5 Recent Developments
9.3 Biomet, Inc. 
      9.3.1 Company Overview
      9.3.2 Financial Overview
      9.3.3 Product Portfolio
      9.3.4 Business Strategies
      9.3.5 Recent Developments
9.4 DePuy Synthes, Inc. (DePuy Mitek Sports Medicine) 
      9.4.1 Company Overview
      9.4.2 Financial Overview
      9.4.3 Product Portfolio
      9.4.4 Business Strategies
      9.4.5 Recent Developments
9.5 Glofinn Oy      
      9.5.1 Company Overview
      9.5.2 Financial Overview
      9.5.3 Product Portfolio
      9.5.4 Business Strategies
      9.5.5 Recent Developments
9.6 Harvest Technologies Corp. 
      9.6.1 Company Overview
      9.6.2 Financial Overview
      9.6.3 Product Portfolio
      9.6.4 Business Strategies
      9.6.5 Recent Developments
9.7 Medira Ltd. 
      9.7.1 Company Overview
      9.7.2 Financial Overview
      9.7.3 Product Portfolio
      9.7.4 Business Strategies
      9.7.5 Recent Developments
9.8 Regen Lab S.A. 
      9.8.1 Company Overview
      9.8.2 Financial Overview
      9.8.3 Product Portfolio
      9.8.4 Business Strategies
      9.8.5 Recent Developments
9.9 Stryker Corporation
      9.9.1 Company Overview
      9.9.2 Financial Overview
      9.9.3 Product Portfolio
      9.9.4 Business Strategies
      9.9.5 Recent Developments
List of Tables
 
TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Europe PRP Market (2013 & 2020) 
TABLE 3 Europe PRP Market Revenue, by Origin, 2012 – 2022 (USD Million) 
TABLE 4 Comparative Analysis of Various PRP Products (Origin) 
TABLE 5 Europe PRP Market Revenue, by Types, 2012 – 2022 (USD Million) 
TABLE 6 Comparative Analysis of Various PRP Products (Types) 
TABLE 7 Europe PRP Market Revenue, by Applications, 2012 – 2022 (USD Million) 
TABLE 8 Europe PRP Market Revenue, by Country, 2012 – 2022 (USD Million) 

List of Figures

 

FIG. 1 Market Segmentation : Europe Platelet Rich Plasma (PRP) Market

FIG. 2 Europe PRP Market, by Types, 2013 (USD Million) 

FIG. 3 Europe PRP Market, by Origin, 2013 (USD Million) 

FIG. 4 Europe PRP Market, by Applications, 2013 (USD Million) 

FIG. 5 Comparative Analysis: Europe PRP Market, by Country, 2013 & 2022 (Value %)

FIG. 6 Value Chain Analysis for Platelet Rich Plasma Market

FIG. 7 Porter’s Five Forces Analysis: Europe Platelet Rich Plasma (PRP) Market

FIG. 8 Market Attractiveness Analysis: Europe PRP Market, by Country, 2013 Value (%)

FIG. 9 Market Share Analysis, by Key Players: Europe Platelet Rich Plasma Market, 2013 (Value %)

FIG. 10 Europe Autologous PRP Market Revenue, 2012 – 2022 (USD Million) 

FIG. 11 Europe Allogenic PRP Market Revenue, 2012 – 2022 (USD Million) 

FIG. 12 Europe Homologous PRP Market Revenue, 2012 – 2022 (USD Million) 

FIG. 13 Europe Pure PRP Market Revenue, 2012 – 2022 (USD Million) 

FIG. 14 Europe Leukocyte Rich PRP Market Revenue, 2012 – 2022 (USD Million) 

FIG. 15 Europe P-PRF/L-PRF Market Revenue, 2012 – 2022 (USD Million) 

FIG. 16 Europe Orthopedic PRP Market Revenue, 2012 – 2022 (USD Million) 

FIG. 17 Europe Cosmetic Surgery PRP Market Revenue, 2012 – 2022 (USD Million) 

FIG. 18 Europe General Surgery PRP Market Revenue, 2012 – 2022 (USD Million) 

FIG. 19 Europe Neurosurgery PRP Market Revenue, 2012 – 2022 (USD Million) 

FIG. 20 Europe Other Surgeries PRP Market Revenue, 2012 – 2022 (USD Million) 

FIG. 21 U.K. PRP Market Revenue, 2012 – 2022 (USD Million) 

FIG. 22 Germany PRP Market Revenue, 2012 – 2022 (USD Million) 

FIG. 23 France PRP Market Revenue, 2012 – 2022 (USD Million) 

FIG. 24 Italy PRP Market Revenue, 2012 – 2022 (USD Million) 

FIG. 25 Spain PRP Market Revenue, 2012 – 2022 (USD Million) 

FIG. 26 Rest of Europe PRP Market Revenue, 2012 – 2022 (USD Million) 

FIG. 27 Biomet, Inc.: Annual Revenue, 2011 – 2013 (USD Million) 

FIG. 28 Stryker Corporation: Annual Revenue, 2011 – 2013 (USD Million) 

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

851

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved